U.S. Capital Markets Stock News

NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

US Stock Market Today: S&P 500 Futures Rise amid Cooling Costs, Resilient Housing Data

The Morning Bull - US Market Morning Update Tuesday, Dec, 16 2025 US stock futures are pointing higher this morning, with contracts tied to the S&P 500 up about half a percent, as investors weigh cooling but still elevated business costs against signs of resilience in housing. The latest New York manufacturing survey slipped back into contraction at minus 3.9, which means factories in that region are pulling back a bit, but it also showed that price pressures are easing, a mild positive for...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Is Nuvation Bio’s 228.6% 2025 Surge Still Supported by Valuation?

If you are wondering whether Nuvation Bio's explosive run means you are late to the party or looking at a genuine opportunity, let's break down what the current price might really be worth. The stock has been on a tear recently, with a 75.1% gain over the last month and a 228.6% jump year to date, even after a small 0.8% pullback over the past week. That surge has been fueled by growing optimism around Nuvation Bio's oncology pipeline and increasing investor attention on small cap biotech...
NasdaqGM:VERI
NasdaqGM:VERISoftware

Veritone (VERI): Assessing Valuation After New AI Partnerships in Digital Evidence and Edge-to-Enterprise Data Workflows

Veritone (VERI) has been on traders radar after a flurry of AI focused deals, from powering Strategic Communications JPS TRUST modernization program to teaming with Armada on edge to enterprise data workflows. See our latest analysis for Veritone. Despite a sharp pullback in the latest session, with a 1 day share price return of minus 8.79 percent and the stock closing at 5.19 dollars, Veritone still shows strong positive momentum. This is supported by a 30 day share price return of 20.70...
NYSE:XHR
NYSE:XHRHotel and Resort REITs

Xenia Hotels & Resorts (XHR) Is Up 7.8% After Retiring Over 25% Of Shares Through Buybacks

Xenia Hotels & Resorts recently completed a major share repurchase program, buying back 3,717,939 shares for US$48.91 million between July 1 and December 4, 2025, and in total retiring 28,230,533 shares for US$377.5 million since the program began in 2015. By shrinking its share count by over a quarter through this long-running buyback, the company has materially increased each remaining investor’s claim on future cash flows and earnings. We’ll now examine how completing this extensive...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Amicus Therapeutics (FOLD) Rides DMX-200 Progress and Bullish Coverage – Is Its Pipeline Undervalued?

In recent days, Dimerix announced that its ACTION3 Phase 3 trial of DMX-200 for focal segmental glomerulosclerosis completed recruitment and dosing of 286 adult patients, while Amicus Therapeutics drew fresh attention after new analyst coverage highlighted the company’s earnings potential. Together, the late-stage progress of DMX-200 and the wave of optimistic research coverage sharpen the focus on Amicus’s pipeline depth and prospects for earnings improvement. Now we’ll examine how this...
NasdaqGS:UDMY
NasdaqGS:UDMYConsumer Services

Udemy (UDMY): Reassessing Valuation After New LG CNS Partnership and AI Microlearning Launch

Udemy (UDMY) just deepened its bet on AI driven upskilling by pairing a new microlearning experience with a fresh partnership with LG CNS that opens doors to hundreds of Korean enterprises and millions of professionals. See our latest analysis for Udemy. Those AI focused partnerships and product launches are landing against a tough backdrop, with Udemy’s share price return down sharply over the year and its three year total shareholder return still deeply negative. This suggests sentiment has...